Abstract
Purpose
To examine the prospective association between serum Mg level and the incidence of cognitive impairment.
Methods
A random sub-cohort (n = 2063) from the Reasons for Geographic and Racial Differences in Stroke (REGARDS) cohort was included in this study. Baseline serum Mg concentration was measured using inductively coupled plasma mass spectrometry. According to the current reference interval of serum magnesium (0.75–0.95 mmol/L), we classified participants below the interval as Level 1 and used it as the referent. The rest of the study population were equally divided into three groups, named Level 2 to 4. Incident cognitive impairment was identified using the Six-Item Screener. Multivariable-adjusted odds ratios (ORs) and corresponding 95% confidence intervals (CIs) were estimated using logistic regression models.
Results
After adjustment for potential confounders, an inverse threshold association between serum Mg level and incident cognitive impairment was observed. Compared to those with hypomagnesemia (Level 1: < 0.75 mmol/L), the relative odds of incident cognitive impairment was reduced by 41% in the second level [OR (95% CI) = 0.59 (0.37, 0.94)]; higher serum Mg level did not provide further benefits [Level 3 and 4 versus Level 1: OR (95% CI) = 0.54 (0.34, 0.88) and 0.59 (0.36, 0.96), P for linear trend = 0.08].
Conclusions
Findings from this prospective study suggest that sufficient Mg status within the normal range may be beneficial to cognitive health in the US general population.
Similar content being viewed by others
References
Wimo A, Jonsson L, Bond J, Prince M, Winblad B, Alzheimer Disease I (2013) The worldwide economic impact of dementia 2010. Alzheimers Dement 9(1):1–11. https://doi.org/10.1016/j.jalz.2012.11.006e13
Karri V, Schuhmacher M, Kumar V (2016) Heavy metals (Pb, Cd, As and MeHg) as risk factors for cognitive dysfunction: a general review of metal mixture mechanism in brain. Environ Toxicol Pharmacol 48:203–213. https://doi.org/10.1016/j.etap.2016.09.016
Poenaru S, Manicom R, Rouhani S et al (1997) Stability of brain content of magnesium in experimental hypomagnesemia. Brain Res 769(2):329–332
Kim SJ, Linden DJ (2007) Ubiquitous plasticity and memory storage. Neuron 56(4):582–592. https://doi.org/10.1016/j.neuron.2007.10.030
Lisman JE, McIntyre CC (2001) Synaptic plasticity: a molecular memory switch. Curr Biol 11(19):R788–791
Roberts EL Jr (1999) Using hippocampal slices to study how aging alters ion regulation in brain tissue. Methods 18(2):150–159. https://doi.org/10.1006/meth.1999.0768
Slutsky I, Abumaria N, Wu LJ et al (2010) Enhancement of learning and memory by elevating brain magnesium. Neuron 65(2):165–177. https://doi.org/10.1016/j.neuron.2009.12.026
Huang Y, Huang X, Zhang L et al (2018) Magnesium boosts the memory restorative effect of environmental enrichment in Alzheimer’s disease mice. CNS Neurosci Ther 24(1):70–79. https://doi.org/10.1111/cns.12775
Bardgett ME, Schultheis PJ, Muzny A, Riddle MD, Wagge JR (2007) Magnesium deficiency reduces fear-induced conditional lick suppression in mice. Magn Res 20(1):58–65
Balmus IM, Strungaru SA, Ciobica A et al (2017) Preliminary data on the interaction between some biometals and oxidative stress status in mild cognitive impairment and Alzheimer’s disease patients. Oxid Med Cell Longev 2017:7156928. https://doi.org/10.1155/2017/7156928
Barbagallo M, Belvedere M, Di Bella G, Dominguez LJ (2011) Altered ionized magnesium levels in mild-to-moderate Alzheimer’s disease. Magnes Res 24(3):S115–121. https://doi.org/10.1684/mrh.2011.0287
Veronese N, Zurlo A, Solmi M et al (2016) Magnesium status in Alzheimer’s disease: a systematic review. Am J Alzheimers Dis Other Demen 31(3):208–213. https://doi.org/10.1177/1533317515602674
Cilliler AE, Ozturk S, Ozbakir S (2007) Serum magnesium level and clinical deterioration in Alzheimer’s disease. Gerontology 53(6):419–422. https://doi.org/10.1159/000110873
Corsonello A, Pedone C, Pahor M et al (2001) Serum magnesium levels and cognitive impairment in hospitalized hypertensive patients. Magnes Res 14(4):273–282
Kieboom BCT, Licher S, Wolters FJ et al (2017) Serum magnesium is associated with the risk of dementia. Neurology 89(16):1716–1722. https://doi.org/10.1212/wnl.0000000000004517
Howard VJ, Cushman M, Pulley L et al (2005) The reasons for geographic and racial differences in stroke study: objectives and design. Neuroepidemiology 25(3):135–143. https://doi.org/10.1159/000086678
Cai J, Zeng D (2004) Sample size/power calculation for case-cohort studies. Biometrics 60(4):1015–1024
Cushman M, Jenny NS, Zakai NA et al (2014) N-terminal pro-B-type natriuretic peptide and stroke risk: the reasons for geographic and racial differences in stroke cohort. Stroke 45(6):1646–1650. https://doi.org/10.1161/STROKEAHA.114.004712
Kabagambe EK, Judd SE, Howard VJ et al (2011) Inflammation biomarkers and risk of all-cause mortality in the reasons for geographic and racial differences in stroke cohort. Am J Epidemiol 174(3):284–292. https://doi.org/10.1093/aje/kwr085
Chen C, Xun P, McClure LA et al (2018) Serum mercury concentration and the risk of ischemic stroke: the reasons for geographic and racial differences in stroke trace element study. Environ Int 117:125–131. https://doi.org/10.1016/j.envint.2018.05.001
Cushman M, McClure LA, Howard VJ, Jenny NS, Lakoski SG, Howard G (2009) Implications of increased C-reactive protein for cardiovascular risk stratification in black and white men and women in the US. Clin Chem 55(9):1627–1636. https://doi.org/10.1373/clinchem.2008.122093
Callahan CM, Unverzagt FW, Hui SL, Perkins AJ, Hendrie HC (2002) Six-item screener to identify cognitive impairment among potential subjects for clinical research. Med Care 40(9):771–781. https://doi.org/10.1097/01.mlr.0000024610.33213.c8
Morris JC, Mohs RC, Rogers H, Fillenbaum G, Heyman A (1988) Consortium to establish a registry for Alzheimer’s disease (CERAD) clinical and neuropsychological assessment of Alzheimer’s disease. Psychopharmacol Bull 24(4):641–652
Rosen WG (1980) Verbal fluency in aging and dementia. J Clin Exp Neuropsychol 2(2):135–146
Benton AL, Sivan AB, de Hamsher K, Varney NR (1994) Contributions to neuropsychological assessment: a clinical manual. Oxford University Press, Oxford
Hachinski V, Iadecola C, Petersen RC et al (2006) National Institute of neurological disorders and stroke-canadian stroke network vascular cognitive impairment harmonization standards. Stroke 37(9):2220–2241. https://doi.org/10.1161/01.Str.0000237236.88823.47
Gillett SR, Thacker EL, Letter AJ et al (2015) Correlates of incident cognitive impairment in the reasons for geographic and racial differences in stroke (REGARDS) study. Clin Neuropsychol 29(4):466–486. https://doi.org/10.1080/13854046.2015.1042524
Pearson KE, Wadley VG, McClure LA, Shikany JM, Unverzagt FW, Judd SE (2016) Dietary patterns are associated with cognitive function in the reasons for geographic and racial differences in stroke (REGARDS) cohort. J Nutr Sci 5:e38. https://doi.org/10.1017/jns.2016.27
Kohout FJ, Berkman LF, Evans DA, Cornoni-Huntley J (1993) Two shorter forms of the CES-D (Center for Epidemiological Studies Depression) depression symptoms index. J Aging Health 5(2):179–193. https://doi.org/10.1177/089826439300500202
Lowenstein FW, Stanton MF (1986) Serum magnesium levels in the United States, 1971-1974. J Am Coll Nutr 5(4):399–414. https://doi.org/10.1080/07315724.1986.10720143
Costello RB, Elin RJ, Rosanoff A et al (2016) Perspective: the case for an evidence-based reference interval for serum magnesium: the time has come. Adv Nutr 7(6):977–993. https://doi.org/10.3945/an.116.012765
Wilmott LA, Thompson LT (2013) Sex- and dose-dependent effects of post-trial calcium channel blockade by magnesium chloride on memory for inhibitory avoidance conditioning. Behav Brain Res 257:49–53. https://doi.org/10.1016/j.bbr.2013.09.047
Levine DA, Galecki AT, Langa KM et al (2015) Trajectory of cognitive decline after incident stroke. JAMA 314(1):41–51. https://doi.org/10.1001/jama.2015.6968
Chui D, Chen Z, Yu J et al (2011) Magnesium in Alzheimer’s disease. In: Vink R, Nechifor M (eds) Magnesium in the central nervous system. University of Adelaide Press, Adelaide
Billard JM (2011) Brain free magnesium homeostasis as a target for reducing cognitive aging. In: Vink R, Nechifor M (eds) Magnesium in the central nervous system. University of Adelaide Press, Adelaide
Furukawa Y, Kasai N, Torimitsu K (2009) Effect of Mg2 + on neural activity of rat cortical and hippocampal neurons in vitro. Magnes Res 22(3):174s–181s
Landfield PW, Morgan GA (1984) Chronically elevating plasma Mg2 + improves hippocampal frequency potentiation and reversal learning in aged and young rats. Brain Res 322(1):167–171
Matsuda H, Saigusa A, Irisawa H (1987) Ohmic conductance through the inwardly rectifying K channel and blocking by internal Mg2+. Nature 325(7000):156–159. https://doi.org/10.1038/325156a0
Slutsky I, Sadeghpour S, Li B, Liu G (2004) Enhancement of synaptic plasticity through chronically reduced Ca2 + flux during uncorrelated activity. Neuron 44(5):835–849. https://doi.org/10.1016/j.neuron.2004.11.013
Xu ZP, Li L, Bao J et al (2014) Magnesium protects cognitive functions and synaptic plasticity in streptozotocin-induced sporadic Alzheimer’s model. PLoS ONE 9(9):e108645. https://doi.org/10.1371/journal.pone.0108645
Neves G, Cooke SF, Bliss TV (2008) Synaptic plasticity, memory and the hippocampus: a neural network approach to causality. Nat Rev Neurosci 9(1):65–75. https://doi.org/10.1038/nrn2303
Hans CP, Chaudhary DP, Bansal DD (2003) Effect of magnesium supplementation on oxidative stress in alloxanic diabetic rats. Magnes Res 16(1):13–19
Yang Y, Wu Z, Chen Y et al (2006) Magnesium deficiency enhances hydrogen peroxide production and oxidative damage in chick embryo hepatocyte in vitro. Biometals 19(1):71–81. https://doi.org/10.1007/s10534-005-6898-1
Nielsen FH (2018) Magnesium deficiency and increased inflammation: current perspectives. J Inflamm Res 11:25–34. https://doi.org/10.2147/jir.s136742
Morais JB, Severo JS, Santos LR et al (2017) Role of magnesium in oxidative stress in individuals with obesity. Biol Trace Elem Res 176(1):20–26. https://doi.org/10.1007/s12011-016-0793-1
Malon A, Brockmann C, Fijalkowska-Morawska J, Rob P, Maj-Zurawska M (2004) Ionized magnesium in erythrocytes–the best magnesium parameter to observe hypo- or hypermagnesemia. Clin Chim Acta 349(1–2):67–73. https://doi.org/10.1016/j.cccn.2004.06.006
Reddy ST, Soman SS, Yee J (2018) Magnesium balance and measurement. Adv Chronic Kidney Dis 25(3):224–229. https://doi.org/10.1053/j.ackd.2018.03.002
Acknowledgements
The authors thank the other investigators, the staff, and the participants of the REGARDS study for their valuable contributions. A full list of participating REGARDS investigators and institutions can be found at http://www.regardsstudy.org.
Funding
This study is supported by a research grant from the NIH (R01AG056111). The REGARDS research project is supported by a National Institute of Neurological Disorders and Stroke, National Institutes of Health, and Department of Health and Human Services cooperative agreement U01-NS-041588. Additional support was provided by Centers for Disease Control and Prevention cooperative agreement U01-DP-006302. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Neurological Disorders and Stroke, the National Institutes of Health, the Centers for Disease Control and Prevention, or the Department of Health and Human Services.
Author information
Authors and Affiliations
Contributions
KH contributed to study concept and design, and acquisition of data. CC analyzed and interpreted data, and drafted manuscript. All co-authors contributed to critical revision of manuscript for intellectual content.
Corresponding author
Ethics declarations
Conflict of interest
None.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Chen, C., Xun, P., Unverzagt, F. et al. Serum magnesium concentration and incident cognitive impairment: the reasons for geographic and racial differences in stroke study. Eur J Nutr 60, 1511–1520 (2021). https://doi.org/10.1007/s00394-020-02353-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00394-020-02353-7